Eberhard Windler

1.2k total citations
26 papers, 734 citations indexed

About

Eberhard Windler is a scholar working on Surgery, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Eberhard Windler has authored 26 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 6 papers in Economics and Econometrics and 5 papers in Molecular Biology. Recurrent topics in Eberhard Windler's work include Lipoproteins and Cardiovascular Health (10 papers), Pharmaceutical Economics and Policy (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Eberhard Windler is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Pharmaceutical Economics and Policy (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Eberhard Windler collaborates with scholars based in Germany, United States and Austria. Eberhard Windler's co-authors include H. Greten, Jobst Greeve, Ulrike Beisiegel†, Birgit‐Christiane Zyriax, Heiner Greten, Christian Otte, Christoph Muhtz, Franz Rinninger, Winfried März and Stefan Jäckle and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and The American Journal of Cardiology.

In The Last Decade

Eberhard Windler

22 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eberhard Windler Germany 13 285 271 129 104 92 26 734
Marilu Fiegenbaum Brazil 17 277 1.0× 176 0.6× 131 1.0× 43 0.4× 85 0.9× 61 891
Anna Wolska United States 16 407 1.4× 167 0.6× 437 3.4× 278 2.7× 119 1.3× 61 913
I. Friedrich Germany 13 259 0.9× 138 0.5× 237 1.8× 81 0.8× 115 1.3× 21 646
Magdalena Jasińska-Stroschein Poland 11 173 0.6× 141 0.5× 59 0.5× 153 1.5× 53 0.6× 56 632
Jane Wilkinson United Kingdom 13 156 0.5× 149 0.5× 148 1.1× 57 0.5× 62 0.7× 21 509
Nicholas Davidson United States 14 268 0.9× 256 0.9× 112 0.9× 55 0.5× 83 0.9× 21 761
Audrey Aguesse France 15 163 0.6× 255 0.9× 109 0.8× 63 0.6× 68 0.7× 29 612
Daniel Bulut Germany 17 116 0.4× 226 0.8× 90 0.7× 208 2.0× 32 0.3× 27 682
E Schaefer United States 12 521 1.8× 99 0.4× 473 3.7× 251 2.4× 110 1.2× 13 952
Patricia D. Maningat United States 8 145 0.5× 169 0.6× 52 0.4× 26 0.3× 57 0.6× 11 581

Countries citing papers authored by Eberhard Windler

Since Specialization
Citations

This map shows the geographic impact of Eberhard Windler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Windler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Windler more than expected).

Fields of papers citing papers by Eberhard Windler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Windler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Windler. The network helps show where Eberhard Windler may publish in the future.

Co-authorship network of co-authors of Eberhard Windler

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Windler. A scholar is included among the top collaborators of Eberhard Windler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Windler. Eberhard Windler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Windler, Eberhard, Heiner K. Berthold, Ioanna Gouni‐Berthold, et al.. (2023). Phytosterols and Cardiovascular Risk Evaluated against the Background of Phytosterolemia Cases—A German Expert Panel Statement. Nutrients. 15(4). 828–828. 12 indexed citations
2.
März, Winfried, Hubert Scharnagl, Ioanna Gouni‐Berthold, et al.. (2016). LDL-Cholesterol: Standards of Treatment 2016: A German Perspective. American Journal of Cardiovascular Drugs. 16(5). 323–336. 17 indexed citations
3.
Laufs, Ulrich, Hubert Scharnagl, Martin Halle, et al.. (2015). Treatment Options for Statin-Associated Muscle Symptoms. Deutsches Ärzteblatt international. 112(44). 748–55. 50 indexed citations
4.
Stock, Stephanie, et al.. (2013). DELIGHT (Delay of impaired glucose tolerance by a healthy lifestyle trial) – A Feasibility Study on Implementing a Program of Sustainable Diabetes Prevention in German Companies. Experimental and Clinical Endocrinology & Diabetes. 122(1). 20–26. 9 indexed citations
5.
Muhtz, Christoph, Birgit‐Christiane Zyriax, Brigitta Bondy, Eberhard Windler, & Christian Otte. (2010). Association of a common mineralocorticoid receptor gene polymorphism with salivary cortisol in healthy adults. Psychoneuroendocrinology. 36(2). 298–301. 13 indexed citations
6.
Muhtz, Christoph, et al.. (2009). Depressive symptoms and metabolic risk: Effects of cortisol and gender. Psychoneuroendocrinology. 34(7). 1004–1011. 65 indexed citations
7.
Windler, Eberhard, et al.. (2009). Current Strategies and Recent Advances in the Therapy of Hypercholesterolemia. Atherosclerosis Supplements. 10(5). 1–4. 6 indexed citations
8.
Færgeman, Ole, et al.. (2008). Efficacy and Tolerability of Rosuvastatin and Atorvastatin when Force-Titrated in Patients with Primary Hypercholesterolemia. Cardiology. 111(4). 219–228. 27 indexed citations
9.
Windler, Eberhard, et al.. (2008). Das klinische Bild der Megadolicho-Basilaris. DMW - Deutsche Medizinische Wochenschrift. 113(36). 1397–1400.
10.
Müller‐Nordhorn, Jacqueline, Heike Englert, Karl Wegscheider, et al.. (2007). Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany. Clinical Research in Cardiology. 97(3). 152–159. 14 indexed citations
11.
Stein, Evan A., Christie M. Ballantyne, Eberhard Windler, et al.. (2007). Efficacy and Tolerability of Fluvastatin XL 80 mg Alone, Ezetimibe Alone, and the Combination of Fluvastatin XL 80 mg With Ezetimibe in Patients With a History of Muscle-Related Side Effects With Other Statins. The American Journal of Cardiology. 101(4). 490–496. 83 indexed citations
12.
13.
14.
Lauterbach, Karl W., Urs Harnischmacher, Daniel R. Ludwig, et al.. (2000). Risk evaluation and stroke prevention in the elderly — Cerivastatin trial (RESPECT). Atherosclerosis. 151(1). 73–74. 1 indexed citations
15.
Jäckle, Stefan, et al.. (1996). Annexins in endocytosis.. PubMed. 34 Suppl 3. 81–2.
16.
Jäckle, Stefan, Ulrike Beisiegel†, Franz Rinninger, et al.. (1994). Annexin VI, a marker protein of hepatocytic endosomes.. Journal of Biological Chemistry. 269(2). 1026–1032. 59 indexed citations
17.
18.
Windler, Eberhard, et al.. (1993). Performance of Helicobacter pylori acid extract and urease enzyme-linked immunosorbent assays in relation to 14C-urea breath test. Zentralblatt für Bakteriologie. 280(1-2). 203–213. 4 indexed citations
19.
Greeve, Jobst, et al.. (1988). The significance of the hepatic LDL-receptor for the metabolism of exogenous cholesterol.. PubMed. 26. 173–9. 1 indexed citations
20.
Greten, Heiner, Eberhard Windler, & Ulrike Beisiegel†. (1986). Receptor-Mediated Uptake in the Liver. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilu Fiegenbaum Breakdown of academic impact, for papers by Anna Wolska Breakdown of academic impact, for papers by I. Friedrich Breakdown of academic impact, for papers by Magdalena Jasińska-Stroschein Breakdown of academic impact, for papers by Jane Wilkinson Breakdown of academic impact, for papers by Nicholas Davidson Breakdown of academic impact, for papers by Audrey Aguesse Breakdown of academic impact, for papers by Daniel Bulut Breakdown of academic impact, for papers by E Schaefer Breakdown of academic impact, for papers by Patricia D. Maningat
Rankless by CCL
2026